Venture Life Group (LON:VLG) Shares Pass Above 50-Day Moving Average – Should You Sell?

Shares of Venture Life Group plc (LON:VLG) passed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of GBX 66.32 and traded as high as GBX 70.40. Venture Life Group shares last traded at GBX 70.35, with a volume of 219,079 shares trading hands.

Venture Life Group Price Performance

The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.48 and a current ratio of 4.71. The firm has a market cap of £84.19 million, a price-to-earnings ratio of 15.88, a price-to-earnings-growth ratio of 5.67 and a beta of 0.22. The company’s fifty day moving average is GBX 66.32 and its two-hundred day moving average is GBX 65.47.

Insider Buying and Selling

In related news, insider Paul McGreevy acquired 93,887 shares of the business’s stock in a transaction on Tuesday, June 30th. The shares were bought at an average cost of GBX 64 per share, with a total value of £60,087.68. Insiders bought 174,094 shares of company stock valued at $11,012,928 over the last 90 days. Company insiders own 7.45% of the company’s stock.

About Venture Life Group

Venture Life is an international consumer self-care company focused on developing and commercialising products for the global self-care market helping our consumers live a longer healthier and more rewarding life.

Headquartered in the UK, the Group’s product portfolio includes Balance Activ in the area of women’s intimate healthcare, Earol® supporting ENT care, Lift and Glucogel product ranges for energy and glucose management and hypoglycaemia, plus the Health & Her product range supporting the hormonal lifecycle.

The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through health & beauty stores, pharmacies, grocery multiples and e-commerce channels and are sold globally.